Hypometabolism of the Left Middle/medial Frontal Lobe on FDG-PET in Anti-NMDA Receptor Encephalitis: Comparison with MRI and EEG Findings

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2023 Feb 23

PMID 36815303

Authors

Chenpeng Zhang

Yong Hao

Gan Huang

Mei Xin

Shuwei Bai

Yangtai Guan

Jianjun Liu

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate changes in brain-glucose metabolism in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, and compare results with MRI and electroencephalography (EEG) findings at different disease stages.

Methods: The clinical data of 18 patients (median age, 35 years; 11 men) were retrospectively collected. Patients were divided into groups based on the time of symptom onset to examination, (≤1 month, >1 but ≤3 months, >3 months). Two-sample t-test results were compared with age and sex-paired healthy controls using statistical parametric mapping and verified using a NeuroQ software normal database with a discriminating z-score of 2.

Results: Abnormal patterns on FDG-PET differed over time (T = 3.21-8.74, Z = 2.68-4.23, p < 0.005). Regional analysis showed hypometabolic left middle or medial frontal cortex in 4/5, 5/7, and 5/6 patients, respectively. Time-subgroup analysis revealed hypermetabolic supertemporal cortex in 4/5, 5/7, and 2/6, patients, respectively. MRI and EEG abnormalities in any region and stage occurred in 10/18 and 10/16 patients, respectively. MRI and EEG time-subgroup analysis showed abnormalities in 5/9, 4/5, and 1/4, and 1/3, 6/7, and 3/6 patients, respectively. Abnormal temporal lobes were detected most frequently in MRI analyses and occurred in 3/10 patients.

Conclusions: Decreased left middle/medial frontal metabolism could be common to all stages. Metabolism in other regions, MRI, and EEG results were associated with the progression of anti-NMDAR encephalitis. The sensitivity rate of FDG-PET was superior to that of MRI and EEG.

Citing Articles

Comparison of cerebral technetium-99m-ethyl cysteinate dimer perfusion in patients with dementia with Lewy bodies and Parkinson's disease dementia.

Toyli A, Hung G, Zhao C, Sha Q, Chiu P, Zhou W Nucl Med Commun. 2024; 46(3):218-222.

PMID: 39711303 PMC: 11798712. DOI: 10.1097/MNM.0000000000001946.

Survival in dogs with meningoencephalomyelitis of unknown etiology with and without lesions detected by magnetic resonance imaging.

Ostrager A, Bentley R, Lewis M, Moore G J Vet Intern Med. 2024; 38(4):2204-2213.

PMID: 38804716 PMC: 11256124. DOI: 10.1111/jvim.17109.

Hypometabolism of the left middle/medial frontal lobe on FDG-PET in anti-NMDA receptor encephalitis: Comparison with MRI and EEG findings.

Zhang C, Hao Y, Huang G, Xin M, Bai S, Guan Y CNS Neurosci Ther. 2023; 29(6):1624-1635.

PMID: 36815303 PMC: 10173717. DOI: 10.1111/cns.14125.

References

Masangkay N, Basu S, Moghbel M, Kwee T, Alavi A . Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 2014; 35(10):1038-46. DOI: 10.1097/MNM.0000000000000163. View

Guo Y, Lv X, Wei Q, Wu Y, Chen Y, Ji Y . Impaired neurovascular coupling and cognitive deficits in anti-N-methyl-D-aspartate receptor encephalitis. Brain Imaging Behav. 2021; 16(3):1065-1076. DOI: 10.1007/s11682-021-00588-4. View

Baumgartner A, Rauer S, Mader I, Meyer P . Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013; 260(11):2744-53. DOI: 10.1007/s00415-013-7048-2. View

Yuan J, Guan H, Zhou X, Niu N, Li F, Cui L . Changing Brain Metabolism Patterns in Patients With ANMDARE: Serial 18F-FDG PET/CT Findings. Clin Nucl Med. 2016; 41(5):366-70. DOI: 10.1097/RLU.0000000000001164. View

Wang H, Xiao Z . Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis. Biomed Res Int. 2020; 2020:7506590. PMC: 7178504. DOI: 10.1155/2020/7506590. View

Turpin S, Martineau P, Levasseur M, Meijer I, Decarie J, Barsalou J . 18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging. Eur J Nucl Med Mol Imaging. 2019; 46(6):1309-1324. DOI: 10.1007/s00259-019-04302-x. View

Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T . Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012; 83(7):681-6. PMC: 3740122. DOI: 10.1136/jnnp-2011-301969. View

Wei Y, Tseng J, Wu C, Su F, Weng W, Hsu C . Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: Case report and literature review. Brain Behav. 2020; 10(3):e01540. PMC: 7066351. DOI: 10.1002/brb3.1540. View

Wang K, Chen Z, Wu D, Ding Q, Zheng X, Wang J . Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis. Ann Clin Transl Neurol. 2019; 6(7):1202-1213. PMC: 6649545. DOI: 10.1002/acn3.50798. View

10.

Moreno-Ajona D, Prieto E, Grisanti F, Esparragosa I, Sanchez Orduz L, Gallego Perez-Larraya J . F-FDG-PET Imaging Patterns in Autoimmune Encephalitis: Impact of Image Analysis on the Results. Diagnostics (Basel). 2020; 10(6). PMC: 7344773. DOI: 10.3390/diagnostics10060356. View

11.

Fan B, Wu P, Zhou X, Chen Z, Pang L, Shi K . Aberrant resting-state interhemispheric functional connectivity in patients with anti-N-methyl-D-aspartate receptor encephalitis. Neuroradiology. 2022; 64(10):2021-2030. DOI: 10.1007/s00234-022-02983-0. View

12.

Probasco J, Benavides D, Ciarallo A, Sanin B, Wabulya A, Bergey G . Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis. Epilepsy Behav Case Rep. 2015; 2:174-8. PMC: 4308031. DOI: 10.1016/j.ebcr.2014.09.005. View

13.

Wegner F, Wilke F, Raab P, Tayeb S, Boeck A, Haense C . Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol. 2014; 14:136. PMC: 4076767. DOI: 10.1186/1471-2377-14-136. View

14.

Wu P, Pang X, Liang X, Wei W, Li X, Zhao J . Correlation analysis between regional homogeneity and executive dysfunction in anti-N-methyl-D-aspartate receptor encephalitis patients. Eur J Neurol. 2021; 29(1):277-285. DOI: 10.1111/ene.15119. View

15.

Bordonne M, Chawki M, Doyen M, Kas A, Guedj E, Tyvaert L . Brain F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis. Eur J Nucl Med Mol Imaging. 2021; 48(12):3847-3858. DOI: 10.1007/s00259-021-05299-y. View

16.

Kang K, Jung K, Choi E, Kim H, Do S, Ko I . Monitoring Physiological Changes in Neutron-Exposed Normal Mouse Brain Using FDG-PET and DW-MRI. Radiat Res. 2019; 193(1):54-62. DOI: 10.1667/RR15405.1. View

17.

Strohm T, Steriade C, Wu G, Hantus S, Rae-Grant A, Larvie M . FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus. AJNR Am J Neuroradiol. 2019; 40(2):238-244. PMC: 7028610. DOI: 10.3174/ajnr.A5929. View

18.

Sanchez-Orduz L, Gallego Perez-Larraya J, Grisanti F, Centeno M, Arbizu J . Caspr2 antibody-associated limbic encephalitis: contribution of visual aided analysis of F-FDG PET images using normal database comparison. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019; 39(2):92-95. DOI: 10.1016/j.remn.2019.08.008. View

19.

Seniaray N, Verma R, Ranjan R, Belho E, Mahajan H . Metabolic Imaging Patterns on 18F-FDG PET in Acute and Subacute LGI1 Autoimmune Limbic Encephalitis. Clin Nucl Med. 2020; 46(1):e27-e28. DOI: 10.1097/RLU.0000000000003258. View

20.

Kerik-Rotenberg N, Diaz-Meneses I, Hernandez-Ramirez R, Munoz-Casillas R, Reynoso-Mejia C, Flores-Rivera J . A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis. Psychosomatics. 2019; 61(1):39-48. DOI: 10.1016/j.psym.2019.08.007. View